- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00500968
Study Assessing the Effect of Transpapillary Pancreas Duct Stent in Resection of the Pancreatic Tail
Randomized Study Assessing the Effect of Transpapillary Pancreas Duct Stent in Resection of the Pancreatic Tail
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Resection of the pancreatic tail is fraught with fistula or leakage of pancreatic enzymes to varying degrees between 13-64%, depending upon which definition one uses. The "downstream" control of the pancreatic duct with the help of a transpapillary stent might minimize the risk for leakage over the transected pancreas surface.
Trial evaluation will be A. The pancreatic bed was drained and postoperatively the fluid was continuously collected and daily analysed for pancreatic amylase and bilirubin. Daily measurement of pancreatic enzyme content in the drain fluid, at least for 5 post operative days or as long as the patient retains the drain. X-Amylase and X-Protein as long as the patient has the external drain.
B. Co-variables measured in the form of: operation time, complications in relation to diagnosis, duration of hospitalization. Patients receiving a pancreas stent are followed in order to evaluate the natural course of the pancreas stent.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Stockholm, Sweden, 14186
- Karolinksa University Hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Inclusion Criteria include all patients planned to undergo resection of the pancreatic body-tail are invited to participate.
Exclusion Criteria:
- The Patients who, at the time of exploration, judged to have a tumour, which is un-resectable.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: RANDOMIZED
- Interventional Model: SINGLE_GROUP
- Masking: NONE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
ACTIVE_COMPARATOR: Stent
|
ERCP guided stent insertion before transection of the gland
Other Names:
|
ACTIVE_COMPARATOR: conventional distal pancreatectomy
|
conventional distal pancreatectomy
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Drain fluid content analyses
Time Frame: At least 5 postoperative days
|
Post-operative daily measurement of X-Amylase,as long as the patient has the external drain and for at least 5 postopertaive days.
|
At least 5 postoperative days
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Co-variables measured in the form of: operation time, complications in relation to diagnosis, duration of hospitalization and cost. Patients receiving a pancreas stent are followed in order to evaluate the natural course of the pancreas stent
Time Frame: At least 5 postoperative days
|
At least 5 postoperative days
|
Collaborators and Investigators
Sponsor
Investigators
- Study Director: Urban Arnelo, Karolinksa University Hospital
- Principal Investigator: Farshad Frozanpor, Karolinksa University Hospital
Publications and helpful links
Study record dates
Study Major Dates
Study Start
Primary Completion (ACTUAL)
Study Completion (ACTUAL)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ESTIMATE)
Study Record Updates
Last Update Posted (ESTIMATE)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2006/3:3
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Fistula
-
University Hospital, AkershusUniversity Hospital, Linkoeping; Region Örebro County; Uppsala University HospitalCompletedPerianal FistulaNorway
-
Mayo ClinicWithdrawnBronchoesophageal Fistula | Tracheoesophageal Fistula | Tracheoesopharyngeal FistulaUnited States
-
London North West Healthcare NHS TrustCompletedFistula in Ano | Ano FistulaUnited Kingdom
-
Rush University Medical CenterTerminatedRectal Fistula | Anal Fistula | Fistula in Ano | Transsphincteric FistulaUnited States
-
Zagazig UniversityCompletedTranssphincteric Anal FistulaEgypt
-
William A. Faubion, M.D.CompletedPerianal Fistula | Cryptoglandular Perianal Fistula | Crohn's Perianal FistulaUnited States
-
Tehran University of Medical SciencesRecruitingFistula PerianalIran, Islamic Republic of
-
Sykehuset Innlandet HFWithdrawn
-
Konstantinos TsimogiannisSuspendedFistula in Ano | Transsphincteric Anal FistulaSweden
-
University of MalayaCompleted
Clinical Trials on stent
-
Zhujiang HospitalNanfang Hospital of Southern Medical University; Guangdong Provincial People...UnknownTrials of Clinical Curative Effect, Follow-up Study and Hemodynamics of Treatment of IA Using StentsTreatment Outcome by Stent-assisted EmbolizationChina
-
Royal Sussex County HospitalTerumo CorporationCompletedCoronary DiseaseUnited Kingdom
-
Southeast University, ChinaUnknownEsophageal CancerChina
-
Chang Gung Memorial HospitalNot yet recruitingVascular Response of Orsiro vs. Xience Drug-Eluting Stents for Treating Coronary Bifurcation LesionsCoronary Artery DiseaseTaiwan
-
Medinol Ltd.CompletedIschemic Heart DiseaseIsrael, Sweden, Belgium, Germany
-
Baylor College of MedicineEunice Kennedy Shriver National Institute of Child Health and Human Development... and other collaboratorsTerminatedVaginal StrictureUnited States
-
Merit Medical Systems, Inc.CompletedVenous Stenosis | Venous OcclusionUnited Kingdom, Greece
-
UMC UtrechtUnknownAcute Coronary Syndrome | Stable Angina PectorisNetherlands, Luxembourg
-
Xijing HospitalChanghai HospitalUnknown
-
Shanghai Jiao Tong University School of MedicineUnknownIntracranial AneurysmsChina